1.
Bioorg Med Chem Lett
; 16(14): 3829-32, 2006 Jul 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-16650987
RESUMO
Efforts toward developing orally bioavailable factor VIIa inhibitors starting from parenteral lead compound 1 are described. SAR resulted in improved physicochemical properties, leading to enhanced oral absorption in rat.